Furosemide Impurity 15 | CAS 137-65-5 - Request Quote
Furosemide Impurity 15
| SZ CAT No: | SZ-F032033 |
| CAS No | 137-65-5 |
| Mol.F. | C7H8N2O4S |
| Mol.Wt. | 216.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Furosemide Impurity 15 is chemically 2-Amino-5-sulfamoylbenzoic acid. Furosemide Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Furosemide Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Furosemide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 137-65-5
Purchase 137-65-5
Order 137-65-5
Enquire 137-65-5
price of 137-65-5
137-65-5 Supplier
137-65-5 Manufacturer
137-65-5 Exporter
buy high quality Furosemide Impurity 15
Purchase Furosemide Impurity 15
Furosemide Impurity 15 suppliers
Furosemide Impurity 15 manufacturers
Furosemide Impurity 15 price
Order Furosemide Impurity 15
Enquire Furosemide Impurity 15
Furosemide Impurity 15 cost
Furosemide Impurity 15 Supplier
Furosemide Impurity 15 Distributor
Furosemide Impurity 15 for Method Validation
Furosemide Reference Standard
Furosemide Impurity 15 for ANDA Filing
Furosemide Impurity 15 for Forced Degradation Studies
Furosemide Impurity 15 Identification Standards
Furosemide Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.